
26/09/2025
Turning Ideas Into Impact! Did you catch SingHealth Group Research at the 8th SingHealth Duke-NUS Scientific Congress? 🌟
At the Medical Technology Accelerators Symposium, Dr Whye Kei Lye, Director of SingHealth Intellectual Property (SHIP) and Dr Danny Belkin, Director of SingHealth Technology Incubator (SCOUT) led dynamic discussion on advancing IP strategy and accelerating the journey from concept to commercialisation in medical technology.
The session featured Mr Fredrik Nyberg, MD of Medtech Innovator; Dr Steve Courtney, Head of 65Lab Singapore; and Lijoy George, Head of DxD hub’s Digital Health Accelerator at Agency for Science, Technology and Research (A*STAR).
The three speakers each introduced their respective platform and how it supports projects and startups within the ecosystem, and these were followed by an interesting and educational panel discussion that focused on the Singapore biomedical technology ecosystem, how the three platforms engage projects and startups and support them, and the nuances of developing and commercialising technologies in the medical device, diagnostic and therapeutic domains.
Across our exhibition booths, visitors explored the capabilities of:
🔬 Advanced Bioimaging (ABI)
🧫 Advanced Molecular Pathology Laboratory (AMPL)
🥼 SingHealth Tissue Repository (STR)
With expertise in bioimaging, molecular pathology and tissue preservation, we are enabling researchers to translate discoveries into real-world impact.
Missed us at the Congress? Find out how we can support your research: singhealthdukenus.com.sg/research